In trading on Monday, shares of the SPDR S&P 400 Mid CapGrowth ETF (Symbol: MDYG) crossed below their 200 day moving average of $92.67, changing hands as low as $92.44 per share. SPDR S&P 400 Mid CapGrowth shares are currently trading down about 1.6% on the day. The ch
In trading on Monday, shares of the SPDR S&P 400 Mid CapGrowth ETF (Symbol: MDYG) crossed below their 200 day moving average of $92.67, changing hands as low as $92.44 per share. SPDR S&P 400 Mid CapGrowth shares are currently trading down about 1.6% on the day. The ch
In trading on Monday, shares of the iShares U.S. Aerospace & Defense ETF (Symbol: ITA) crossed below their 200 day moving average of $211.06, changing hands as low as $209.33 per share. iShares U.S. Aerospace & Defense shares are currently trading off about 3% on the da
In trading on Monday, shares of the iShares U.S. Aerospace & Defense ETF (Symbol: ITA) crossed below their 200 day moving average of $211.06, changing hands as low as $209.33 per share. iShares U.S. Aerospace & Defense shares are currently trading off about 3% on the da
Niles Investment Management Founder & Portfolio Manager Dan Niles discusses the fall in tech stocks since the outset of the war in Iran, why software is 'nowhere near the bottom,' and how agentic AI will drive tech's next phase higher. He talks with Katie Greifeld and Bailey Lipschultz on "The Close." (Source: Bloomberg)
Niles Investment Management Founder & Portfolio Manager Dan Niles discusses the fall in tech stocks since the outset of the war in Iran, why software is 'nowhere near the bottom,' and how agentic AI will drive tech's next phase higher. He talks with Katie Greifeld and Bailey Lipschultz on "The Close." (Source: Bloomberg)
The US military is upgrading White House facilities for the new East Wing, the administration said on Monday, after US President Donald Trump said the ballroom would be built atop a “massive” fortified complex. “The military is making some upgrades to their facilities here at the White House and I’m not privy to provide any more details on that,” White House spokeswoman Karoline Leavitt said at ...
The US military is upgrading White House facilities for the new East Wing, the administration said on Monday, after US President Donald Trump said the ballroom would be built atop a “massive” fortified complex. “The military is making some upgrades to their facilities here at the White House and I’m not privy to provide any more details on that,” White House spokeswoman Karoline Leavitt said at a press briefing. Leavitt’s comments followed Trump’s own update on the US$400 million White House...
In trading on Monday, shares of the iShares Global Industrials ETF (Symbol: EXI) crossed below their 200 day moving average of $175.72, changing hands as low as $175.03 per share. iShares Global Industrials shares are currently trading off about 1.1% on the day. The chart belo
In trading on Monday, shares of the iShares Global Industrials ETF (Symbol: EXI) crossed below their 200 day moving average of $175.72, changing hands as low as $175.03 per share. iShares Global Industrials shares are currently trading off about 1.1% on the day. The chart belo
NANCHANG, China, March 30, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun” or the “Company”), an innovative artificial intelligence (“AI”) driven education technology company focused on developing and delivering AI-enabled digital education platforms, including intelligent learning tools, assessment platforms, and adaptive learning systems, today announced its unaud...
NANCHANG, China, March 30, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun” or the “Company”), an innovative artificial intelligence (“AI”) driven education technology company focused on developing and delivering AI-enabled digital education platforms, including intelligent learning tools, assessment platforms, and adaptive learning systems, today announced its unaudited interim financial results for the six months ended September 30, 2025.
Service Properties Trust ( SVC ) has initiated a $500M underwritten public offering of common shares. Proceeds will primarily be used to redeem 2027 senior notes totaling up to $550M. Underwriters have a 30-day option to purchase up to an additional 15% of shares. Helix Partners and The RMR Group indicated interest in buying up to $100M and $50M of shares, respectively. Company executives and boar...
Service Properties Trust ( SVC ) has initiated a $500M underwritten public offering of common shares. Proceeds will primarily be used to redeem 2027 senior notes totaling up to $550M. Underwriters have a 30-day option to purchase up to an additional 15% of shares. Helix Partners and The RMR Group indicated interest in buying up to $100M and $50M of shares, respectively. Company executives and board members also expressed non-binding interest in participating in the offering. SVC plans to add an independent trustee with hotel expertise to strengthen governance. More on Service Properties Trust Service Properties Trust: Debt Crisis Overshadows Strategic Pivot Service Properties Trust (SVC) Q4 2025 Earnings Call Transcript Small-Cap real estate stocks ranked by quant ratings after earnings season Service Properties Trust outlines $500M-$520M adjusted EBITDAre guidance for 2026 amid continued asset sales and debt reduction Seeking Alpha’s Quant Rating on Service Properties Trust
In trading on Monday, shares of Encore Energy Corp (Symbol: EU) entered into oversold territory, changing hands as low as $1.67 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on
In trading on Monday, shares of Encore Energy Corp (Symbol: EU) entered into oversold territory, changing hands as low as $1.67 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on
In trading on Monday, shares of The Gap Inc (Symbol: GAP) crossed below their 200 day moving average of $23.90, changing hands as low as $23.42 per share. The Gap Inc shares are currently trading off about 4.1% on the day. The chart below shows the one year performance of GAP
In trading on Monday, shares of The Gap Inc (Symbol: GAP) crossed below their 200 day moving average of $23.90, changing hands as low as $23.42 per share. The Gap Inc shares are currently trading off about 4.1% on the day. The chart below shows the one year performance of GAP
In trading on Monday, shares of Motorola Solutions Inc (Symbol: MSI) crossed below their 200 day moving average of $427.34, changing hands as low as $426.43 per share. Motorola Solutions Inc shares are currently trading down about 2.6% on the day. The chart below shows the one
In trading on Monday, shares of Motorola Solutions Inc (Symbol: MSI) crossed below their 200 day moving average of $427.34, changing hands as low as $426.43 per share. Motorola Solutions Inc shares are currently trading down about 2.6% on the day. The chart below shows the one
In trading on Monday, shares of Macy's Inc (Symbol: M) crossed below their 200 day moving average of $17.81, changing hands as low as $17.45 per share. Macy's Inc shares are currently trading down about 2.5% on the day. The chart below shows the one year performance of M share
In trading on Monday, shares of Macy's Inc (Symbol: M) crossed below their 200 day moving average of $17.81, changing hands as low as $17.45 per share. Macy's Inc shares are currently trading down about 2.5% on the day. The chart below shows the one year performance of M share
Noko LTD/E+ via Getty Images The last time I spoke about Neumora Therapeutics ( NMRA ), it was with a Seeking Alpha article entitled " Neumora: Kostal-1 Readout For MDD Treatment Is First Study On Deck ." With respect to this article, I mentioned that it would release data from its KOASTAL-1 study using its drug navacaprant for the treatment of patients with major depressive disorder [MDD] by the ...
Noko LTD/E+ via Getty Images The last time I spoke about Neumora Therapeutics ( NMRA ), it was with a Seeking Alpha article entitled " Neumora: Kostal-1 Readout For MDD Treatment Is First Study On Deck ." With respect to this article, I mentioned that it would release data from its KOASTAL-1 study using its drug navacaprant for the treatment of patients with major depressive disorder [MDD] by the end of 2024. It finally released results from this, the first of three replicate studies from its KOASTAL program. Today, I'm downgrading this stock to a "Hold" rating from a "Strong Buy" rating. The first reason is because of the fact that it failed to achieve the primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo. The company did change the protocol for the other studies as part of the KOASTAL program, KOASTAL-2 and KOASTAL-3, which is a good thing. It increased enrollment for each of these studies and expects a topline data readout from each in Q2 of 2026. While this approach might end up working out, the fact is that the company has a steep uphill battle to climb here, in my opinion. It's still a risk, as increasing the number of patients is not guaranteed to generate a study win. The second reason why I'm downgrading to keep this stock at a "Hold" rating is because the company did achieve a highly successful outcome using another drug from its pipeline, known as V1aR antagonist NMRA-511, to treat patients with Alzheimer's Disease [AD] agitation. In the modified analysis set [MAS], with a total of 71 patients given this drug with twice-daily [BID] dosing, achieved a placebo-adjusted change from baseline on the CMAI total score of -2.6 and -2.1 was achieved at weeks 6 and 8, respectively. A further enhanced effect of CMAI score in the same time period in patients with elevated anxiety was achieved. The thing is that this was a signal-finding study, and this study was not powered to detect statistical significance. Wh...
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
Lexeo Therapeutics press release ( LXEO ): Q4 GAAP EPS of -$0.27 beats by $0.04 . As of December 31, 2025, cash, cash equivalents, and investments in marketable securities were $246.6 million, which Lexeo believes will be sufficient to fund operations into 2028. More on Lexeo Therapeutics Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transc...
Lexeo Therapeutics press release ( LXEO ): Q4 GAAP EPS of -$0.27 beats by $0.04 . As of December 31, 2025, cash, cash equivalents, and investments in marketable securities were $246.6 million, which Lexeo believes will be sufficient to fund operations into 2028. More on Lexeo Therapeutics Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on Lexeo Therapeutics Historical earnings data for Lexeo Therapeutics
Never miss an episode. Follow The Big Take daily podcast today. SpaceX is preparing for liftoff. After months of speculation, the company could file for a historic IPO as early as this week — seeking $75 billion in funding that would push the company’s value to $1.75 trillion. On today’s Big Take podcast, Bloomberg Tech’s Ed Ludlow joins David Gura to break down the timing of the mega-offering. Th...
Never miss an episode. Follow The Big Take daily podcast today. SpaceX is preparing for liftoff. After months of speculation, the company could file for a historic IPO as early as this week — seeking $75 billion in funding that would push the company’s value to $1.75 trillion. On today’s Big Take podcast, Bloomberg Tech’s Ed Ludlow joins David Gura to break down the timing of the mega-offering. They discuss the challenges SpaceX could face taking its Mars-focused mission public, how the move could push Elon Musk’s net worth past the $1 trillion mark and what this all means for everyday investors looking to get in on the action. Read more: Is SpaceX Worth $1.75 Trillion? Key Questions for Musk’s Big IPO Listen and follow The Big Take on Apple Podcasts , Spotify or wherever you get your podcasts. Terminal clients: click here to subscribe. This episode was produced by: Julia Press; Editors: Tracey Samuelson and Jeffrey Grocott; Fact-checker: Eleanor Harrison-Dengate; Sound Design/Engineer: Alex Sugiura; Senior Producer: Naomi Shavin; Senior Editor: Elisabeth Ponsot; Deputy Executive Producer: Julia Weaver; Executive Producer: Nicole Beemsterboer.